We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oncolytics Biotech® Completes Patient Enrollment in U.S. Phase 2 Clinical Trial

News   Apr 06, 2011

 
Oncolytics Biotech® Completes Patient Enrollment in U.S. Phase 2 Clinical Trial
 
 
Advertisement
 

RELATED ARTICLES

Large Clinical Trial To Test Polyclonal Antibody Therapeutic for COVID-19

News

A trial evaluating a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-19.

READ MORE

Encouraging Early Results From Clinical Trial of Gene Therapy for Childhood Blindness

News

According to a clinical trial, a new gene therapy for one of the most common forms of congenital blindness was safe and improved patients’ vision.

READ MORE

Large Trial To Investigate Repurposed Drugs To Treat Mild-to-Moderate COVID-19

News

The large, randomized, placebo‑controlled Phase 3 clinical trial will explore up to seven drugs approved by US Food and Drug Administration (FDA) for other conditions – an approach called drug repurposing – and test their safety and effectiveness in treating mild-to-moderate COVID-19.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE